KTTA (STOCKS)
Pasithea Therapeutics Corp. Common Stock
$0.560000
-0.031100 (-5.26%)
Prev close: $0.591100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Tiago Reis Marques
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18.59M
- Employees
- 4
- P/E (TTM)
- -0.27
- P/B (TTM)
- 0.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.12 | $-0.46 | +0.3390 | +73.86% |
|
Dec 2025 (Q4)
|
$-0.79 | $-0.18 | -0.6064 | -330.28% |
|
Dec 2024 (Q4)
|
$-2.41 | $0.00 | +0.0000 | +0.00% |
|
Mar 2022 (Q1)
|
$-1.40 | $-0.41 | -0.9920 | -243.14% |
Financial Statements
| Nonoperating Income/Loss | $2.32M |
| Research and Development | $9.19M |
| Operating Income/Loss | -$22.05M |
| Income/Loss From Continuing Operations After Tax | -$19.73M |
| Income/Loss From Continuing Operations Before Tax | -$19.73M |
| Net Income/Loss | -$19.73M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.73M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.73M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.08 |
| Diluted Earnings Per Share | -$2.08 |
| Basic Average Shares | 39,335,845 |
| Diluted Average Shares | 39,335,845 |
| Assets | $56.35M |
| Current Assets | $52.73M |
| Prepaid Expenses | $1.83M |
| Other Current Assets | $50.90M |
| Noncurrent Assets | $3.62M |
| Liabilities | $1.54M |
| Current Liabilities | $1.49M |
| Noncurrent Liabilities | $52.97K |
| Equity | $54.81M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $54.81M |
| Liabilities And Equity | $56.35M |
| Net Cash Flow From Operating Activities | -$16.94M |
| Net Cash Flow From Operating Activities, Continuing | -$16.94M |
| Net Cash Flow From Investing Activities | $3.22M |
| Net Cash Flow From Investing Activities, Continuing | $3.22M |
| Net Cash Flow From Financing Activities | $62.05M |
| Net Cash Flow From Financing Activities, Continuing | $62.05M |
| Net Cash Flow | $48.34M |
| Net Cash Flow, Continuing | $48.32M |
| Comprehensive Income/Loss | -$19.69M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.68M |
| Other Comprehensive Income/Loss | -$15.97M |